Very early / early Onset Schizophrenia and drug response: a complex binomial

Downloads

Published

2015-03-27

How to Cite

Diéguez Quintairos, A., Domínguez Santos, M. D., Mazaira Castro, J., Varela Reboiras, L., & del Río Casanova, L. (2015). Very early / early Onset Schizophrenia and drug response: a complex binomial. Revista De Psiquiatría Infanto-Juvenil, 32(1), 67–69. Retrieved from https://aepnya.eu/index.php/revistaaepnya/article/view/116

Issue

Vol. 32 No. 1 (2015)

Section

Case reports

Authors

  • Antía Diéguez Quintairos Complexo Hospitalario de Santiago de Compostela
  • María Dolores Domínguez Santos Complexo Hospitalario de Santiago de Compostela
  • José Mazaira Castro Complexo Hospitalario de Santiago de Compostela
  • Lucía Varela Reboiras Complexo Hospitalario de Santiago de Compostela
  • Lucía del Río Casanova Complexo Hospitalario de Santiago de Compostela

Keywords:

EOS, VEOS, Refractory/Refractoriness, clozapine

Abstract

Early onset schizophrenia (EOS-under 15 years-) and very early onset schizophrenia (VEOS-under 13 years-) is a rare condition (12-33% and 1% of all cases respectively) which continues with adult schizophrenia, but has a worse prognosis due to associating more varied symptoms and a poorer response to psychopharmacological treatment (first-line drugs fail in 50% of patients, considering at this age, too, clozapine as third line treatment in refractory cases)

Downloads

Download data is not yet available.

Author Biography

Antía Diéguez Quintairos, Complexo Hospitalario de Santiago de Compostela

Santiago de Compostela, A Coruña

References

1. Castro-Fornieles J, Parellada M, Soutullo CA, et al. Antipsychotic treatment in child and adolescent First-Episode Psychosis: A Longitudinal Naturalistic Approach. J Child Adolesc Psychopharmacol 2008; 18: 327-36.

2. Fourneret P, Georgieff N, Franck N. Early onset schizophrenia: Current data and therapeutic approach. Arch Pediatr 2013; 20 (7): 789-99.

3. Clinical practice guideline for schizophrenia and incipient psychotic disorder. Clinical practice guideline: CAHTA; no. 2006/05-2.

4. Gogtay N, Rapoport J. Clozapine use in children and adolescents. Expert Opin Pharmacother 2008; 9 (3): 459-465.

5. Actualización en esquizofrenia ultrarresistente al tratamiento. Cap.11: Potenciación de la clozapina con antipsicóticos atípicos: Amisulpride. Coord: Espiño Díaz I, Ramos Ríos R.

6. Tufan A, Yalug I. Clozapine augmented with amisulpride in 3 cases of Treatment –Resistant Early-and Very Early-Onset Schizophrenia. J Clin Psychopharmacol 2013; 33: 572-574.